BioInsights - Nonclinical tools update: are they improving in their capabilities of predicting clinical responses? - spotlight

IMMUNO-ONCOLOGY INSIGHTS

September 2022

Nonclinical tools update: are they improving in their capabilities of predicting clinical responses?

Download PDF

Foreword

To a mouse

To a mouse

Róisin McGuigan

24 September 2022

Expert Insight

Preclinical models for development of immune–oncology therapies

Preclinical models for development of immune–oncology therapies

Y Wang, S Shelton, G Kastrunes et al.

26 September 2022

Commentary

Translational mouse models for immuno-oncology: from syngeneic to humanized models

Translational mouse models for immuno-oncology: from syngeneic to humanized models

Stephanie C Casey

27 September 2022

Interview

Bispecifics come of age: how preclinical tools are helping drive translation to the clinic

Bispecifics come of age: how preclinical tools are helping drive translation to the clinic

Michelle Morrow

Review

Agonistic antibodies targeting 4-1BB for cancer immunotherapy

Agonistic antibodies targeting 4-1BB for cancer immunotherapy

Hyewon Phee

Viewpoint

Harnessing components of the immune system in bioengineered 3D tumor models

Harnessing components of the immune system in bioengineered 3D tumor models

Aleksander Skardal

7 September 2022

Webinars

Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Chris Hughes

Overcoming current challenges in immunotherapy drug development with patient-derived organoids

Overcoming current challenges in immunotherapy drug development with patient-derived organoids

Sylvia F. Boj

Accelerating immuno-oncology innovation using humanized mouse models

Accelerating immuno-oncology innovation using humanized mouse models

Santi Suryani Chen, PhD.

21 September 2022